Unraveling Hybrid Clinical Trials: Challenges And Opportunities
Hybrid trials — in which patients participate from home for some visits/activities, rather than in a clinical setting — have undergone rapid evolution in the past few years. Conceived more than a decade ago and thrust into prominence during the COVID-19 pandemic, hybrid clinical trials now have become the rule, rather than the exception. Sponsors and their partners progress further every day into more effective implementation of decentralized methodologies, supporting technologies, and other tools to promote the generation of more accurate data and streamline regulatory review, as well as reduce investigator and patient burdens.
This e-book examines how hybrid trials’ journey has taken place in recent years — the reasons for confidence and concern — and examines how hybrid trials may impact pharmaceutical development in the future.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.